You are here

Zetia

Merck, Glenmark wrap up Zetia pay-for-delay case after pharmacies take settlement

Merck, Glenmark wrap up Zetia pay-for-delay case after pharmacies take settlement

Fierce Pharma

Flag link:

In Zetia antitrust case, Merck and Glenmark ink deals with 2 plaintiff groups as retailers hold out

In Zetia antitrust case, Merck and Glenmark ink deals with 2 plaintiff groups as retailers hold out

Fierce Pharma

Flag link:

Merck, Glenmark headed to trial after judge scraps early dismissal bid in Zetia antitrust case

Merck, Glenmark headed to trial after judge scraps early dismissal bid in Zetia antitrust case

Fierce Pharma

Flag link:

Insurers sue Merck for 'monopolistic scheme' to delay generics of blockbuster cholesterol drug

Insurers sue Merck for 'monopolistic scheme' to delay generics of blockbuster cholesterol drug

BioPharma Dive

Flag link:

Kaiser Sues Merck, Generic Drug Firm Over Millions in Losses Due to Alleged "Pay-for-Delay" Scheme

Kaiser Sues Merck, Generic Drug Firm Over Millions in Losses Due to Alleged "Pay-for-Delay" Scheme

BioSpace

Kaiser Permanente

Flag link:

Merck to spin off new $6.5 billion firm focused on women’s health, older drugs

Merck to spin off new $6.5 billion firm focused on women’s health, older drugs

Stat

Flag link:

Esperion's Cholesterol Combo Pill Cuts Bad Cholesterol 35%

Esperion's Cholesterol Combo Pill Cuts Bad Cholesterol 35%

Forbes

Esperion Therapeutics

Flag link:

Esperion shares bounce up on an effective triplet approach to slashing LDL

Esperion shares bounce up on an effective triplet approach to slashing LDL

Endpoints

LDL cholesterol

Flag link:

Endo Begins Shipment of Generic ZETIA®

Endo Begins Shipment of Generic ZETIA®

Yahoo

Endo International

Par Pharmaceutical

Flag link:

3 Big Pharma Stocks With Credible Threats to Their Blockbusters

3 Big Pharma Stocks With Credible Threats to Their Blockbusters

24/7 Wall St

Atossa Genetics

Flag link:

Merck says U.S. FDA rejects its claim that Zetia and Vytorin cut heart risk

Merck says U.S. FDA rejects its claim that Zetia and Vytorin cut heart risk

Yahoo/Reuters

Flag link:

Patent Expirations Of Crestor And Zetia And The Impact On Other Cholesterol Drugs

Patent Expirations Of Crestor And Zetia And The Impact On Other Cholesterol Drugs

Forbes

Flag link:

Merck poised to win bigger market for cholesterol-fighting Zetia

Merck poised to win bigger market for cholesterol-fighting Zetia

Fierce Pharma

Flag link:

Merck's 'landmark' Zetia data hits NEJM, giving a boost to all LDL-fighting meds

Merck's 'landmark' Zetia data hits NEJM, giving a boost to all LDL-fighting meds

Fierce Biotech

New England Journal of Medicine

Flag link:

Can study data spur Merck CV sales?

Can study data spur Merck CV sales?

Medical Marketing and Media

Flag link:

A Day Of Reckoning Approaches For Merck And Its Critics

A Day Of Reckoning Approaches For Merck And Its Critics

Forbes

Flag link:

U.S. gene study raises hope for Merck cholesterol drug Zetia

U.S. gene study raises hope for Merck cholesterol drug Zetia

Yahoo/Reuters

Flag link:

Does a Positive Result for the Vytorin Trial Really Help Merck?

Does a Positive Result for the Vytorin Trial Really Help Merck?

WSJ Pharmalot

clinical trial data

Flag link:

Merck expects no writedowns for Zetia, Vytorin cholesterol drugs

Merck expects no writedowns for Zetia, Vytorin cholesterol drugs

Yahoo/Reuters

Flag link:

Esperion shares rally on cholesterol drug study results

Esperion shares rally on cholesterol drug study results

Marketwatch

Esperion Therapeutics

Flag link:

Pages